The Friends of Children with Leukemia and Cancer Foundation (FANLYC, Fundación Amigos de Niños con Leucemia y Cáncer, in Spanish) will receive support from the alliance between the insurance company Sagicor and Ducruet that join efforts and launch to the Panamanian market the “Triple Protector” plan.

The “Triple Protector” is an insurance plan payable in life and which offers coverage before three critical illnesses: cancer, stroke and myocardial infarction; and in case of not using it, the premiums are going to be returned at the age of 70, in a single payment.

Ricardo Arango, General Manager of Sagicor Insurance Company explained that for the acquisition of each “Triple Protector” plan, Sagicor and Ducruet will contribute a percentage of the sales that will be used for promoting the early detection of childhood cancer and the prevention of cancer in our country.

The Triple Protector is an insurance product (not underwritten) of coupon that pays a benefit for the diagnosis of a critical illness, with non-renewable and non-convertible coverage up to the age of 70.

The plan can be bought by individuals between the ages of 20 and 60, based on composed risk, which means, that there will not be any distinction between smokers and non-smokers and the insured parties are accepted based upon the answers given to a simple questionnaire.

The insured parties can choose the minimum insured amount 10,000.00 and 30,000.00 the maximum.

This benefit equals 100% of the insured amount that was chosen by the insured party as long as the diagnosis occurs 180 days after the policy had been issued. The following illnesses are covered: myocardial infarction, cancer, and stroke.

In case of death, due to any reason, -the beneficiaries described in the application- will be given back the premiums that were paid up to the time of death.

If upon reaching the age of 70, the insured party did not file claims against the policy in force, he/she shall be entitled to the refund of 100% of the premiums paid, becoming in this way a savings.